A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

Dana Farber Cancer Institute

Boston, Massachusetts, United States, 02215

Contact: Geoffrey Shapiro    877-338-7425      

Principal Investigator: Geoffrey Shapiro         

Karmanos Cancer Institute

Detroit, Michigan, United States, 48201

Contact: Jas Grewal-Karwa    313-576-8932    karwaj@karmanos.org   

Principal Investigator: Anthony Shields         

Cross Cancer Institute

Edmonton, Alberta, Canada, T6G 1Z2

Contact: Bonnie Chalmers    (780) 432-8248    Bonnie.Chalmers@albertahealthservices.ca   

Principal Investigator: Quincy Chu         

Juravinski Cancer Center

Hamilton, Ontario, Canada, L8V 5C2

Contact: Robin Eady    905-387-9711 ext 64422    ready@HHSC.CA   

Principal Investigator: Holger Hirte         

Ottawa Hospital Cancer Centre

Ottawa, Ontario, Canada, K1H 8L6

Contact: Deborah Keller    (613) 247-3518    djonker@toh.on.ca   

Principal Investigator: Derek Jonker         

University Health Network – Princess Margaret Hospital

Toronto, Ontario, Canada, M5G 2M9

Contact: Amit Oza    416-946-4501 ext 2818      

Principal Investigator: Amit Oza         

Jewish General Hospital

Montreal, Quebec, Canada, H3T 1E2

Contact: Wilson Miller    514-340-8222      

Principal Investigator: Wilson Miller         

McGill University Health Centre

Montreal, Quebec, Canada, H4A 3J1

Contact: Nathaniel Bouganim    514-934-1934 ext 35800      

Contact: Rosie Santos    514 934-1934 ext: 44328    rosalia.santos@muhc.mcgill.ca   

Principal Investigator: Nathaniel Bouganim         

Centre Hospitalier de l’Université de Montréal

Montréal, Quebec, Canada, H2X 0A9

Contact: Diane Provencher    514-890-8444    diane.provencher.chum@ssss.gouv.qc.ca   

Principal Investigator: Diane Provencher         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 14, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments